Several immunosuppressive treatments have demonstrated their efficacy in idiopathic membranous nephropathy, but spontaneous remission does develop in more than 30% of patients. The availability of a validated biomarker that is easy to measure and able to accurately predict long-term outcomes would be very helpful for tailoring treatment of the disease to the individual.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Fervenza, F. C., Sethi, S. & Specks, U. Idiopathic membranous nephropathy: diagnosis and treatment. Clin. J. Am. Soc. Nephrol. 3, 905–919 (2008).
van den Brand, J. A., Hofstra, J. M. & Wetzels, J. F. Prognostic value of risk score and urinary markers in idiopathic membranous nephropathy. Clin. J. Am. Soc. Nephrol. http://dx.doi.org/10.2215/CJN.00670112.
Polanco, N. et al. Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy. J. Am. Soc. Nephrol. 21, 697–704 (2010).
Cattran, D. C. et al. Validation of a predictive model of idiopathic membranous nephropathy: its clinical and research implications. Kidney Int. 51, 901–907 (1997).
Branten, A. J. et al. Urinary excretion of β2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: a validation study. J. Am. Soc. Nephrol. 16, 169–174 (2005).
du Buf-Vereijken, P. W., Branten, A. J. & Wetzels, J. F. Idiopathic membranous nephropathy: outline and rationale of a treatment strategy. Am. J. Kidney Dis. 46, 1012–1029 (2005).
van den Brand, J. A., Hofstra, J. M. & Wetzels, J. F. Low-molecular-weight proteins as prognostic markers in idiopathic membranous nephropathy. Clin. J. Am. Soc. Nephrol. 6, 2846–2853 (2011).
Beck, L. H. Jr & Salant, D. J. Membranous nephropathy: recent travels and new roads ahead. Kidney Int. 77, 765–770 (2010).
Hofstra, J. M., Beck, L. H. Jr, Beck, D. M., Wetzels, J. F. & Salant, D. J. Antiphospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin. J. Am. Soc. Nephrol. 6, 1286–1291 (2011).
Beck, L. H. Jr et al. Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J. Am. Soc. Nephrol. 22, 1543–1550 (2011).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Praga, M., Rojas-Rivera, J. Predicting outcomes in idiopathic membranous nephropathy. Nat Rev Nephrol 8, 496–498 (2012). https://doi.org/10.1038/nrneph.2012.161
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2012.161
This article is cited by
-
Treatment of idiopathic membranous nephropathy
Nature Reviews Nephrology (2013)